Background illustration for clinical trials search

Paid Clinical Trials Bronx

Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New York NY, New Haven CT, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase 1, Recruiting

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for
Duchene Muscular Dystrophy
Location: New York NY, Worcester MA, Boston MA,
Sponsor: ITF Therapeutics LLC

Sex: All

Age: 6+

Code: NCT07127978

Recruiting

Adaptive Recruitment Curve Analysis Using Bayesian Modeling

for
Modeling of Recruitment Curves
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18 - 70+

Code: NCT07561372

Recruiting

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

for
Pancreatic Cyst
Location: New York NY, Harrison NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06305728

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: New York NY, Lake Success NY, Philadelphia PA,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

International CDKL5 Clinical Research Network

for
CDKL5, CDKL5 Deficiency Disorder, CDD
Location: New York NY, Philadelphia PA, Boston MA, Cleveland OH,
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 70+

Code: NCT05558371

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: New York NY, Poughkeepsie NY, Haddon Heights NJ,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

for
Atrial Fibrillation
Location: New York NY, Columbus OH, Evanston IL, Overland Park KS
Sponsor: Volta Medical

Sex: All

Age: 21+

Code: NCT06056271

Recruiting

JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency

for
SHANK3 Haploinsufficiency, Phelan-McDermid Syndrome
Location: New York NY, Boston MA, Chicago IL
Sponsor: Jaguar Gene Therapy, LLC

Sex: All

Age: 2 - 9

Code: NCT06662188

Phase 1, Phase 2, Recruiting

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

for
Nontuberculous Mycobacteria, Bronchiectasis
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT02779478

Recruiting

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: New York NY, Boston MA, Canton OH, Detroit MI,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: New York NY, Hackensack NJ, East Brunswick NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

for
Metastatic Brain Cancer
Location: West Islip NY
Sponsor: Good Samaritan Hospital Medical Center, New York

Sex: All

Age: 18+

Code: NCT01890278

Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

for
Leiomyosarcoma
Location: New York NY, Boston MA, Columbus OH, Ann Arbor MI,
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 0+

Code: NCT05653388

Recruiting

Teclistamab-Daratumumab in AL Amyloidosis

for
Amyloid Light-chain Amyloidosis
Location: New York NY, Milwaukee WI
Sponsor: Rajshekhar Chakraborty, MD

Sex: All

Age: 18 - 70+

Code: NCT07110844

Phase 2, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: New Hyde Park NY, Valhalla NY, Morristown NJ,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, New Haven CT, Cleveland OH, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

Tissue Repository: CTCL Collection Protocol

for
Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis,
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT02840747

Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, Houston TX
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT07408258

Phase 1, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: New York NY, Hartford CT, Philadelphia PA, Boston MA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting